vs
Side-by-side financial comparison of MEDIFAST INC (MED) and SMITH & WESSON BRANDS, INC. (SWBI). Click either name above to swap in a different company.
SMITH & WESSON BRANDS, INC. is the larger business by last-quarter revenue ($124.7M vs $75.1M, roughly 1.7× MEDIFAST INC). On growth, SMITH & WESSON BRANDS, INC. posted the faster year-over-year revenue change (-3.9% vs -36.9%). SMITH & WESSON BRANDS, INC. produced more free cash flow last quarter ($16.3M vs $-6.6M). Over the past eight quarters, SMITH & WESSON BRANDS, INC.'s revenue compounded faster (-4.8% CAGR vs -34.4%).
Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.
Smith & Wesson Brands, Inc. (S&W) is an American firearm manufacturer headquartered in Maryville, Tennessee, United States.
MED vs SWBI — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $75.1M | $124.7M |
| Net Profit | — | $1.9M |
| Gross Margin | 69.4% | 24.3% |
| Operating Margin | -10.4% | 3.3% |
| Net Margin | — | 1.5% |
| Revenue YoY | -36.9% | -3.9% |
| Net Profit YoY | — | -53.6% |
| EPS (diluted) | $-1.64 | $0.04 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $75.1M | $124.7M | ||
| Q3 25 | $89.4M | $85.1M | ||
| Q2 25 | $105.6M | $140.8M | ||
| Q1 25 | $115.7M | $115.9M | ||
| Q4 24 | $119.0M | $129.7M | ||
| Q3 24 | $140.2M | $88.3M | ||
| Q2 24 | $168.6M | $159.1M | ||
| Q1 24 | $174.7M | $137.5M |
| Q4 25 | — | $1.9M | ||
| Q3 25 | $-2.3M | $-3.4M | ||
| Q2 25 | $2.5M | $8.6M | ||
| Q1 25 | $-772.0K | $2.1M | ||
| Q4 24 | — | $4.5M | ||
| Q3 24 | $1.1M | $-1.9M | ||
| Q2 24 | $-8.2M | $27.9M | ||
| Q1 24 | $8.3M | $7.9M |
| Q4 25 | 69.4% | 24.3% | ||
| Q3 25 | 69.5% | 25.9% | ||
| Q2 25 | 72.6% | 28.8% | ||
| Q1 25 | 72.8% | 24.1% | ||
| Q4 24 | 74.1% | 26.6% | ||
| Q3 24 | 75.4% | 27.4% | ||
| Q2 24 | 73.2% | 35.5% | ||
| Q1 24 | 72.8% | 28.7% |
| Q4 25 | -10.4% | 3.3% | ||
| Q3 25 | -4.6% | -3.5% | ||
| Q2 25 | -1.0% | 9.3% | ||
| Q1 25 | -1.1% | 4.1% | ||
| Q4 24 | 0.6% | 5.8% | ||
| Q3 24 | 1.5% | -1.7% | ||
| Q2 24 | -4.7% | 17.4% | ||
| Q1 24 | 4.5% | 8.2% |
| Q4 25 | — | 1.5% | ||
| Q3 25 | -2.5% | -4.0% | ||
| Q2 25 | 2.3% | 6.1% | ||
| Q1 25 | -0.7% | 1.8% | ||
| Q4 24 | — | 3.5% | ||
| Q3 24 | 0.8% | -2.1% | ||
| Q2 24 | -4.8% | 17.5% | ||
| Q1 24 | 4.8% | 5.7% |
| Q4 25 | $-1.64 | $0.04 | ||
| Q3 25 | $-0.21 | $-0.08 | ||
| Q2 25 | $0.22 | $0.19 | ||
| Q1 25 | $-0.07 | $0.05 | ||
| Q4 24 | $0.08 | $0.10 | ||
| Q3 24 | $0.10 | $-0.04 | ||
| Q2 24 | $-0.75 | $0.60 | ||
| Q1 24 | $0.76 | $0.17 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.3M | $22.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $198.9M | $363.2M |
| Total Assets | $248.0M | $548.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.3M | $22.4M | ||
| Q3 25 | $173.5M | $18.0M | ||
| Q2 25 | $162.7M | $25.2M | ||
| Q1 25 | $164.6M | $26.7M | ||
| Q4 24 | $162.3M | $39.1M | ||
| Q3 24 | $170.0M | $35.5M | ||
| Q2 24 | $163.5M | $60.8M | ||
| Q1 24 | $156.4M | $47.4M |
| Q4 25 | $198.9M | $363.2M | ||
| Q3 25 | $214.7M | $364.4M | ||
| Q2 25 | $216.0M | $372.5M | ||
| Q1 25 | $211.0M | $366.9M | ||
| Q4 24 | $210.1M | $371.5M | ||
| Q3 24 | $207.3M | $380.0M | ||
| Q2 24 | $205.3M | $399.9M | ||
| Q1 24 | $211.0M | $376.4M |
| Q4 25 | $248.0M | $548.6M | ||
| Q3 25 | $268.2M | $554.6M | ||
| Q2 25 | $269.3M | $559.6M | ||
| Q1 25 | $280.0M | $578.9M | ||
| Q4 24 | $284.2M | $587.4M | ||
| Q3 24 | $291.2M | $571.3M | ||
| Q2 24 | $293.5M | $577.4M | ||
| Q1 24 | $302.8M | $570.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-5.3M | $27.3M |
| Free Cash FlowOCF − Capex | $-6.6M | $16.3M |
| FCF MarginFCF / Revenue | -8.8% | 13.1% |
| Capex IntensityCapex / Revenue | 1.8% | 8.8% |
| Cash ConversionOCF / Net Profit | — | 14.22× |
| TTM Free Cash FlowTrailing 4 quarters | $1.2M | $21.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-5.3M | $27.3M | ||
| Q3 25 | $12.1M | $-8.1M | ||
| Q2 25 | $-3.4M | $40.8M | ||
| Q1 25 | $3.4M | $-9.8M | ||
| Q4 24 | $-4.9M | $-7.4M | ||
| Q3 24 | $9.1M | $-30.8M | ||
| Q2 24 | $13.1M | $43.7M | ||
| Q1 24 | $7.3M | $25.2M |
| Q4 25 | $-6.6M | $16.3M | ||
| Q3 25 | $10.8M | $-12.4M | ||
| Q2 25 | $-4.8M | $33.5M | ||
| Q1 25 | $1.9M | $-16.1M | ||
| Q4 24 | $-7.2M | $-10.7M | ||
| Q3 24 | $7.7M | $-35.5M | ||
| Q2 24 | $11.1M | $38.2M | ||
| Q1 24 | $5.4M | $7.0M |
| Q4 25 | -8.8% | 13.1% | ||
| Q3 25 | 12.0% | -14.6% | ||
| Q2 25 | -4.5% | 23.8% | ||
| Q1 25 | 1.6% | -13.9% | ||
| Q4 24 | -6.1% | -8.3% | ||
| Q3 24 | 5.5% | -40.2% | ||
| Q2 24 | 6.6% | 24.0% | ||
| Q1 24 | 3.1% | 5.1% |
| Q4 25 | 1.8% | 8.8% | ||
| Q3 25 | 1.5% | 5.0% | ||
| Q2 25 | 1.3% | 5.2% | ||
| Q1 25 | 1.3% | 5.4% | ||
| Q4 24 | 1.9% | 2.5% | ||
| Q3 24 | 1.0% | 5.3% | ||
| Q2 24 | 1.1% | 3.5% | ||
| Q1 24 | 1.1% | 13.2% |
| Q4 25 | — | 14.22× | ||
| Q3 25 | — | — | ||
| Q2 25 | -1.36× | 4.73× | ||
| Q1 25 | — | -4.68× | ||
| Q4 24 | — | -1.63× | ||
| Q3 24 | 8.04× | — | ||
| Q2 24 | — | 1.57× | ||
| Q1 24 | 0.88× | 3.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
